FACEIA
FACEIA applies AI to speed up and improve accuracy in diagnosing rare genetic diseases in infants and children. It uses a neural network to analyze facial features from images and combines that data with patient and genetic information. This medical device–grade technology supports healthcare providers by offering diagnostic insights as an aid in clinical workflows. The system is designed for hospitals and clinics, operating as a B2B AI tool in pediatrics with a focus on rare diseases. The technology targets the pediatric rare-disease diagnosis market and aims to scale across healthcare settings.
FACEIA
FACEIA applies AI to speed up and improve accuracy in diagnosing rare genetic diseases in infants and children. It uses a neural network to analyze facial features from images and combines that data with patient and genetic information. This medical device–grade technology supports healthcare providers by offering diagnostic insights as an aid in clinical workflows. The system is designed for hospitals and clinics, operating as a B2B AI tool in pediatrics with a focus on rare diseases. The technology targets the pediatric rare-disease diagnosis market and aims to scale across healthcare settings.